trial

Social Cognitive Training for Psychosis: Treatment Development

NCTId NCT01579422
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 1 · Completed
Enrollment 77 (actual)
Sponsored by Yale University
Primary completion 2015-08
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 1
Status
Completed
Enrollment
77 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2012-05
Primary completion
2015-08
Eligibility
ALL · 18 Years · 55 Years

Interventions & indications

Drugs
social cognitive training

Sponsors

Yale UniversityLead Sponsor
National Institute of Mental Health (NIMH)Collaborator

Sites

1 total
West Haven, United States

Facts & assertions

4 sourced
Enrollment
77
Phase
PHASE1
Primary Completion Date
2015-08
Status
COMPLETED
relationships
The graph out of here
drug
social cognitive training
drug
lead_sponsor
Yale University
company
collaborator
National Institute of Mental Health (NIMH)
company
indication
Schizophrenia
indication
Psychosis
indication
Schizophrenia
indication